Hormonal
Combining tirzepatide with leptin produces synergistic weight loss and improved metabolic homeostasis in diet-induced obesity models, driven by reduced food intake and increased energy expenditure.
For individuals with obesity who have leptin resistance, adding leptin to tirzepatide treatment may enhance weight loss and metabolic health beyond what tirzepatide achieves alone. This synergy works by reducing food intake and increasing energy expenditure, suggesting that combination therapies targeting multiple hormonal pathways can overcome resistance mechanisms.
Tirzepatide and leptin synergistically promote weight loss through reduced food intake and increased energy expenditure.
Why this rating
Strong preclinical evidence in DIO mice with mechanistic depth; supported by human clinical trial correlation data.
Source
Tirzepatide Synergizes with Leptin on Weight Loss and Restoring Metabolic Homeostasis in Diet-induced Obesity Model
Xun Sun et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2025
DOI 10.64898/2025.12.18.695152
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →